Fisher PG, Tontiplaphol A, Pearlman EM, et al.Childhood cerebellar hemangioblastoma does not predict germline or somatic mutations in the von Hippel-Lindau tumor suppressor gene. Ann Neurol. 2002;51:257-260.
2.
Sutton LN, Lasner T, Hunter J, et al.Thirteen-year-old female with hemangioblastoma. Pediatr Neurosurg. 1997;27:50-55.
3.
Kepes JJ, Slowik F.Arvid Lindau's cerebellar hemangioblastoma 70 years later. Some pediatric aspects. Ann NY Acad Sci. 1997;824:112-123.
4.
Neumann HP, Eggert HR, Weigel K, et al.Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989;70:24-30.
5.
Neumann HP, Eggert HR, Scheremet R, et al.Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry. 1992;55: 898-901.
6.
Wizigmann-Voos S, Plate KH.Pathology, genetics and cell biology of hemangioblastomas. Histol Histopathol. 1996;11:1049-1061.
7.
Conway JE, Chou D, Clatterbuck RE, et al.Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55-62; discussion 62-53.
8.
Maddock IR, Moran A, Maher ER, et al.A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33: 120-127.
9.
Maher ER, Yates JR, Harries R, et al.Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77:1151-1163.
10.
Melmon KL, Rosen SW.Lindau's Disease. Review of the literature and study of a large kindred. Am J Med. 1964;36:595-617.
11.
Choyke PL, Glenn GM, Walther MM, et al.von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194:629-642.
12.
Karsdorp N, Elderson A, Wittebol-Post D, et al.Von Hippel-Lindau disease: new strategies in early detection and treatment. Am J Med. 1994;97:158-168.
13.
Niemela M, Lemeta S, Summanen P, et al.Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochir (Wien). 1999;141:1147-1156.
14.
Iliopoulos O.von Hippel-Lindau disease: genetic and clinical observations. Front Horm Res. 2001;28:131-166.
15.
Pasztor A SL, Dobronyi I, Szenasy J, Harmat G.Angioblastoma of the posterior fossa in children. J Pediatr Neurosci. 1985;1:281-285.
16.
Van Velthoven V, Reinacher PC, Klisch J, et al.Treatment of intramedullary hemangioblastomas, with special attention to von Hippel-xLindau disease. Neurosurgery. 2003;53: 1306-1313; discussion 1313-1304.
17.
Weil RJ, Lonser RR, DeVroom HL, et al.Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98:95-105.
18.
Lonser RR, Weil RJ, Wanebo JE, et al.Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98:106-116.
Piribauer M, Czech T, Dieckmann K, et al.Stabilization of a progressive hemangioblastoma under treatment with thalidomide. J Neurooncol. 2004;66:295-299.
21.
Zbar B, Kaelin W, Maher E, Richard S.Third International meeting on von Hippel-Lindau disease. Cancer Res. 1999;59:2251-2253.
22.
Maynard MA, Ohh M.Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol. 2004;24:1-13.
Friedrich CA.Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer. 1999;86(11 suppl):2478-2482.
25.
Glasker S, Bender BU, Apel TW, et al.Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 2001;70:644-648.
26.
Gijtenbeek JM, Jacobs B, Sprenger SH, et al.Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. J Neurosurg. 2002;97:977-982.
27.
Neumann HP.Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome. Vasa. 1987;16:220-226.
28.
Couch V, Lindor NM, Karnes PS, Michels VV.von Hippel-Lindau disease. Mayo Clin Proc. 2000;75:265-272.
29.
Bourdillon PJ, Hickman RC.Von Hippel-Lindau's disease presenting at an early age. J Neurol Neurosurg Psychiatry. 1967;30:559-562.
30.
Glasker S, Bender BU, Apel TW, et al.The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry. 1999;67:758-762.
31.
Nichols KE, Li FP, Haber DA, Diller L.Childhood cancer predisposition: applications of molecular testing and future implications. J Pediatr. 1998; 132(3 Pt 1):389-397.
32.
Alliance vH-LF.Fourth International Symposium. (The VHL Handbook). http://www.vhl.org/conf2000/consensus.htm. Accessed September 14, 2005.
